Related Experiment Videos
Psychosis in Parkinson's disease
B R Thanvi1, T C N Lo, D P Harsh
1Department of Medicine for Older People, Leicester General Hospital, University Hospitals of Leicester NHS Trust, Leicester LE5 4PW, UK. bthanvi@hotmail.com
Postgraduate Medical Journal
|October 8, 2005
Summary
Psychosis is a common symptom in Parkinson's disease (PD), impacting quality of life. Newer antipsychotics can manage PD psychosis effectively without worsening motor symptoms.
Area of Science:
- Neurology
- Psychiatry
Background:
- Psychosis is a frequent and debilitating non-motor symptom in Parkinson's disease (PD), especially in advanced stages.
- Symptoms vary from mild illusions and dreams to severe visual hallucinations and frank psychosis.
- The underlying mechanisms of psychosis in PD remain incompletely understood.
Purpose of the Study:
- To review the current understanding of psychosis in Parkinson's disease.
- To discuss management strategies, including the role of newer atypical antipsychotics.
- To highlight the impact of PD psychosis on patient and caregiver quality of life.
Main Methods:
- Literature review of studies on Parkinson's disease psychosis.
- Analysis of clinical data regarding symptom presentation and management.
- Evaluation of the efficacy and safety of atypical antipsychotics in PD patients.
Main Results:
- Psychosis in PD presents a spectrum of symptoms, significantly affecting patient well-being.
- A multidisciplinary approach is crucial for effective management.
- Certain newer atypical antipsychotics demonstrate efficacy in treating PD psychosis without exacerbating motor deficits.
Conclusions:
- Psychosis is a significant challenge in Parkinson's disease management.
- Atypical antipsychotics offer a promising therapeutic option for PD-related psychosis.
- Addressing psychosis is essential for improving the quality of life for patients with Parkinson's disease and their caregivers.